NL-OMON32168尚未招募不适用
Evaluation of FGF-23 suppressibility by Calcitonin in Healthy Men- pilot study - FGF-23 suppressibility by Calcitonin
Rijnstate Ziekenhuis0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy, male sex, age 20-55 years
排除标准
- •Serum creatinin > 100 micromol/L, or glomerular filtration rate < 80 ml/min;
- •Abnormal serum calcium, phosphate, albumin, vitamin D, or PTH level;
- •Any medication;
研究者
相似试验
已完成
不适用
FGF-23 Suppressibility by CalcitoninHypophosphatemiaNCT00688077Rijnstate Hospital49
已完成
早期 1 期
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseChronic Kidney DiseaseNCT01308242Milton S. Hershey Medical Center40
招募中
不适用
Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study.Chronic kidney diseaseJPRN-UMIN000020652ational Hospital Organization Kyushu Medical Center99,999
已完成
4 期
Effect of Pioglitazone on Serum FGF-23 Levels in Patients with Diabetic Kidney Disease: A Randomized Controlled TrialT2DM CKD stage 3-4 patientsT2DMCKD stage 3-4 patientsTCTR20210316009one46
已完成
不适用
The effects of FGF23 and Klotho on vascular calcification in end stage renal disease patients;<br>NL-OMON47072Catharina-ziekenhuis70